CAMH study identifies barriers to treating depression among workers OMA eyes legal challenge after Ontario government refuses binding arbitrationAnnouncement comes after facilitator-led appeals process fails Printing ourselves: 3D Printing and the future of medical devices Australian High Court decision hailed by opponents of gene patents Are doctors being made the scapegoat for our broken healthcare system? A new era in oncology Immune checkpoint inhibitors are poised to revolutionize cancer treatment Humalog KwikPen 200 units/mL: new higher-strength pen now available More concentrated product for patients who need more than 20 units of rapid-acting insulin per day. CMPA and Ontario battle over $250-million malpractice fund deficit OMA wants to be involved in the discussions Type 2 diabetes: The new drugs in town What you need to know about sodium- glucose linked transporter 2 inhibitors Photo gallery: Welcome distractions First Previous 2304 2305 2306 2307 2308 Next Last
